Why the study?
Endothelial dysfunction is a pathogenetic link in many cardiovascular diseases, and determining specific blood biomarkers may offer a promising approach to non-invasive diagnostics and assessment of its severity.
Key points are not available for this paper at this time.
Design
Review
Several molecular factors emerge as candidate endothelial dysfunction biomarkers; extends pathophysiologic insights but leaves clinical adoption open.
Endothelial dysfunction (ED) is a pathogenetic link in many cardiovascular diseases. One of the promising approaches to non-invasive diagnostics and assessment of the ED severity may be the determination of specific blood biomarkers. This review is devoted to the pathogenetic role of some biochemical and molecular factors associated with ED, as potential biomarkers of noncommunicable diseases.
No takes yet. Share an insight, caveat, or question.
Timofeev et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: